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INTRODUCTION
Arteriovenous fistulae (AVF) are created for hemodialysis for patients who have end-stage renal disease. Though creation of AVF is a common procedure done for patients who require long-term hemodialysis, it has its own complications. An important complication is that of aneurismal dilatation of the venous end which can rupture and cause hemorrhage which could be fatal.
There are many causes for aneurysm formation which include intrinsic weakness in the venous graft used for the fistula, repeated punctures at clustered sites which weaken the wall and proximal stenosis which accelerates the process of aneurysm formation by raising the pressure in the AVF. The incidence of aneurysm formation in AVF for hemodialysis access is about 5 to 6% (1).
We report a case of a 61-year-old gentleman who presented with a giant aneurysm of a left brachiocephalic arteriovenous fistula which grew over a period of 7 years after its creation.
CASE REPORT
A 61-year-old Caucasian gentleman with end-stage renal disease underwent creation of a left antecubital radiocephalic AV fistula (side to end) for hemodialysis access 7 years ago. The patient had a successful renal transplant 1 year after the AVF surgery and then the patient was off dialysis.
The patient eventually noticed swelling in the forearm and lower third of the arm. During the office visit 5 years ago, it was found that the patient was developing aneurismal dilatation of the fistula. He also developed swelling of left hand due to venous hypertension (Fig. 1 ). The patient was advised to undergo surgery but due to personal reasons he postponed surgery for the past 5 years though he was fully aware of the risk of aneurismal rupture. The aneurysm grew to enormous size to cover the whole of his forearm (Fig. 2) . The patient finally agreed to excision of the aneurysm and stated that he wanted the surgery for cosmetic reasons. The patient was discharged home on the same day and was followed up at the outpatient office. The incision healed well and no flap necrosis was encountered (Fig. 6) . The patient is scheduled for a second stage removal of the remaining aneurismal vein in the following month.
DISCUSSION
Autogenous arteriovenous fistulae (AVF) are created for hemodialysis in patients with end-stage renal disease. Thrombosis accounts for 90% of the complications of autogenous arteriovenous fistulae (2) . True aneurysms are most likely to occur in native AVF and their overall incidence is poorly defined. It is found to be approximately 5% to 6%.
After renal transplantation, the possibility of spontaneous AVF closure caused by thrombosis is not a rare event. The definite indications for AVF closure in well functioning renal transplanted patients are heart failure, high flow fistula, vascular access complications like aneurysm, ischemia, infections and important aesthetic reasons (3) . The indications for operating venous aneurysms are progressively increasing size, thrombosis or an overlying skin lesion (4) .
Management of AVF aneurysms depends upon their size and extent. Focal aneurysms can be managed either with interposition, replacement with vein or a prosthesis, or, if the wall is fairly thick, resection and imbrication to a size that matches the remainder of the access.
The modalities to treat an aneurysm of AVF which are less invasive include manual ligation and compressing under ultrasonographic guidance, endovascular graft implantation, embolization, and thrombin injection under ultrasonographic guidance (5) .
In our patient, the aneurysm was enlarged to an extent that may cause rupture. The patient also had a good-functioning transplanted kidney and hence a decision for excision without a salvage technique was made. We were able to excise the aneurysm only partially for fear of skin flap necrosis. Our patient was satisfied with the outcome of the surgery. His left hand swelling also improved after the procedure. The patient wishes to have a second stage complete resection of the AVF aneurysm which we plan to do in the near future.
